Literature DB >> 6508279

Treatment of severe Parkinson's disease by intraventricular injection of dopamine.

N Venna, T D Sabin, J I Ordia, V H Mark.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6508279     DOI： 10.1159/000101204

Source DB:  PubMed          Journal:  Appl Neurophysiol


× No keyword cloud information.
  4 in total

1.  Future of cell and gene therapies for Parkinson's disease.

Authors:  Ole Isacson; Jeffrey H Kordower
Journal:  Ann Neurol       Date:  2008-12       Impact factor: 10.422

2.  Intracerebroventricular dopamine for Parkinson's disease.

Authors:  David Devos; Jean-Christophe Devedjian; Caroline Moreau
Journal:  Oncotarget       Date:  2017-07-11

Review 3.  Pathophysiological Mechanisms and Experimental Pharmacotherapy for L-Dopa-Induced Dyskinesia.

Authors:  Andrea Fabbrini; Andrea Guerra
Journal:  J Exp Pharmacol       Date:  2021-04-29

4.  Implanted reuptake-deficient or wild-type dopaminergic neurons improve ON L-dopa dyskinesias without OFF-dyskinesias in a rat model of Parkinson's disease.

Authors:  A Vinuela; P J Hallett; C Reske-Nielsen; M Patterson; T D Sotnikova; M G Caron; R R Gainetdinov; O Isacson
Journal:  Brain       Date:  2008-11-06       Impact factor: 13.501
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.